Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of "Reduce" by Analysts
Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) has been assigned an average recommendation of "Reduce" from the fourteen ratings firms that are currently covering the stock, MarketBeat...